Warner Chilcott announces strong quarterly results
Northern Ireland pharmaceutical company Warner Chilcott, previously known as Galen Holdings PLC, has announced its latest quarterly results for the period ended June 30.
Revenues from continuing operations, excluding revenues from sell-offs, were $113.9m (€92.8m), an increase of 13% over the same quarter last year.





